Axogen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Axogen and other ETFs, options, and stocks.

About AXGN

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. 

CEO
Michael D. Dale
CEOMichael D. Dale
Employees
452
Employees452
Headquarters
Alachua, Florida
HeadquartersAlachua, Florida
Founded
1977
Founded1977
Employees
452
Employees452

AXGN Key Statistics

Market cap
776.92M
Market cap776.92M
Price-Earnings ratio
-159.89
Price-Earnings ratio-159.89
Dividend yield
Dividend yield
Average volume
1.01M
Average volume1.01M
High today
$17.03
High today$17.03
Low today
$16.66
Low today$16.66
Open price
$17.00
Open price$17.00
Volume
17.30K
Volume17.30K
52 Week high
$21.00
52 Week high$21.00
52 Week low
$9.22
52 Week low$9.22

AXGN News

Simply Wall St 4d
Is FDA Review Delay and Legal Scrutiny Altering the Investment Case for Axogen?

Axogen recently announced that the FDA has extended the Prescription Drug User Fee Act goal date for its Biologics License Application for Avance Nerve Graft by...

Is FDA Review Delay and Legal Scrutiny Altering the Investment Case for Axogen?

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AXGN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.